DCV, SOF and RBV combination effective / tolerated in HCV with adv, cirrhosis / post-transplant recurrence
Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with …